| Description |
1 online resource (312 pages) |
| Contents |
The Artificial Heart -- Copyright -- Acknowledgments -- Preface -- Contents -- The Artificial Heart -- Executive Summary -- TECHNOLOGICAL PROGRESS AND BARRIERS -- MAKING DECISIONS ABOUT FUTURE RESEARCH -- CLINICAL EFFECTIVENESS -- PROJECTED PATIENT NEED -- HEALTH-RELATED QUALITY OF LIFE -- COST-EFFECTIVENESS -- APPROPRIATENESS OF USE OF MECHANICAL CIRCULATORY SUPPORT -- PATIENT ACCESS TO MCSSS -- ETHICAL CONSIDERATIONS -- RESEARCH AND DEVELOPMENT POLICY ISSUES -- REGULATORY DECISIONS ABOUT NEW TECHNOLOGIES -- DEVELOPMENT OF TOTAL ARTIFICIAL HEARTS |
|
CONTINUED DEVELOPMENT OF VENTRICULAR ASSIST DEVICESADDITIONAL RESEARCH -- USING THIS REPORT -- 1 The Artificial Heart Program: Current Status and History -- END-STAGE HEART DISEASE -- HOW LONG-TERM IMPLANTABLE DEVICES COULD HELP -- Ventricular Assist Devices -- Total Artificial Hearts -- Temporary Circulatory Support -- THE ARTIFICIAL HEART PROGRAM -- THE INSTITUTE OF MEDICINE STUDY -- REFERENCES -- 2 Total Artificial Hearts: Technological Potential and Research and Development Costs -- TEMPORARY CIRCULATORY SUPPORT -- LONG-TERM DEVICES UNDER DEVELOPMENT |
|
ENGINEERING ASSESSMENT OF MECHANICAL CIRCULATORY SUPPORT DEVICESMechanical Failure -- Device Components as Limiting Factors -- Device Longevity -- CLINICAL COMPLICATIONS WITH MECHANICAL CIRCULATORY SUPPORT DEVICES -- ALTERNATIVE TECHNOLOGIES FOR PREVENTING AND TREATING END-STAGE HEART DISEASE -- Conventional Medical Treatment -- Other Cardiac Assistance Technologies -- Heart Transplantation -- SUMMARY OF THE CURRENT AND FUTURE STATE OF TOTAL ARTIFICIAL HEART TECHNOLOGY -- RESEARCH AND DEVELOPMENT COSTS OF TOTAL ARTIFICIAL HEARTS -- Stages of the Innovative Process |
|
Support for the Artificial Heart ProgramConsidering the Costs of Research and Development to Industry -- CONCLUSIONS -- REFERENCES -- 3 Decisions for Future Research and Development -- ALLOCATING RESEARCH FUNDS -- JUDGMENT-BASED DECISION MAKING -- QUANTIFIED AIDS TO DECISION MAKING -- Cost-Effectiveness Analysis -- Application of Methods -- DECISION-MAKING AIDS SUGGESTED BY THE COMMITTEE -- Explicit Criteria for Allocation of Funds -- The More Important Criteria -- Important Criteria -- Less Important Criteria -- Application of Decision Criteria |
|
A NOTE ABOUT INDUSTRY RESEARCH AND DEVELOPMENT DECISIONSSUMMARY AND CONCLUSIONS -- REFERENCES -- 4 Clinical Effectiveness and Need For Long-Term Circulatory Support -- ESTIMATING THE NEED FOR LONG-TERM SUPPORT -- FROM TEMPORARY TO LONG-TERM USE -- PROJECTING DEVICE RELIABILITY AND EFFECTIVENESS -- RELATING CLINICAL EFFECTIVENESS AND DEVICE USE -- The Role of Comorbidities -- OTHER INFLUENCES ON THE USE OF CIRCULATORY SUPPORT DEVICES -- The Impact of Other Heart Disease Treatment Technologies -- Quality-of-Life Determinants |
| Notes |
""Patient Preferences for Life-Sustaining Treatment"" |
|
Print version record |
| Subject |
National Heart and Lung Institute. Artificial Heart Program.
|
| SUBJECT |
National Heart and Lung Institute. Artificial Heart Program fast |
| Subject |
Heart, Artificial.
|
|
Heart, Artificial
|
|
Heart, Artificial
|
| Form |
Electronic book
|
| Author |
VanAntwerp, Malin
|
|
P, Committee Staff to Evaluate the Artificial Heart
|
| ISBN |
9780309556002 |
|
0309556007 |
|
